Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

617
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
617
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

42
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can machine learning predict endometrial cancer in patients with postmenopausal uterine bleeding?

Przeglad menopauzalny = Menopause review·2026
Same author

Does a larger estimated fetus compared with prior birthweight increase the risk of cesarean delivery after a prior vaginal birth?

Archives of gynecology and obstetrics·2026
Same author

Long-term maternal health outcomes following autologous in vitro fertilization compared with medically unassisted conceptions and with nulliparas.

Journal of assisted reproduction and genetics·2026
Same author

Does the number of abnormal values in the oral glucose tolerance test impact pregnancy outcomes?

BMC pregnancy and childbirth·2026
Same author

Is a history of cesarean section a predictive factor for the failure of medical management in spontaneous abortion?

Archives of gynecology and obstetrics·2026
Same author

Membrane sweeping versus double-balloon catheter for cervical ripening: A randomized controlled trial.

American journal of obstetrics & gynecology MFM·2026

Related Experiment Video

Updated: Sep 23, 2025

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

10.1K

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Gal Cohen1,2, Maya Shavit1,2, Netanella Miller1,2

  • 1Department of Obstetrics and Gynecology, Meir Medical Center, Kfar-Saba, Israel.

Plos One
|May 13, 2022
PubMed
Summary

Intra-muscular-7α-hydroxyprogesterone caproate (17P) may prolong pregnancies in women with a history of spontaneous preterm birth (sPTB). This suggests 17P could reduce complications from premature delivery for those with prior sPTB due to premature contractions or membrane rupture.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

Related Experiment Videos

Last Updated: Sep 23, 2025

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

10.1K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • A history of spontaneous preterm birth (sPTB) is a significant risk factor for recurrence.
  • Intra-muscular-7α-hydroxyprogesterone caproate (17P) was a common preventive treatment for sPTB.
  • Recent studies, like the "Prolong study," have questioned the efficacy of 17P.

Purpose of the Study:

  • To evaluate the effectiveness of 17P in preventing recurrent sPTB.
  • To assess 17P's impact based on the initial sPTB's presenting symptoms: premature contractions (PMC) and preterm premature rupture of membranes (pPROM).

Main Methods:

  • Retrospective analysis of 342 women with a prior singleton sPTB.
  • Subsequent pregnancies were analyzed for sPTB due to PMC (n=145) or pPROM (n=197).
  • Comparison of outcomes between women who received 17P (n=90) and those who did not, analyzing symptom recurrence and pregnancy duration.

Main Results:

  • Women treated with 17P had delivered earlier in their previous pregnancy compared to untreated women.
  • The 17P-treated group showed higher admission rates for suspected preterm labor in the subsequent pregnancy.
  • Treatment with 17P significantly prolonged pregnancy duration in the subsequent pregnancy for both PMC and pPROM groups compared to non-treatment.

Conclusions:

  • 17P may offer an individual benefit by delaying preterm delivery in women with a history of sPTB.
  • The findings suggest that 17P could potentially decrease complications associated with premature delivery for patients with prior sPTB.
  • The presenting symptom of sPTB tends to recur, with a higher likelihood in cases of PMC, irrespective of 17P treatment.